Ticker LaunchRegulation A · Tier 2
CancerVAX, Inc.
CancerVAX, Inc. filed a Tier 2 Regulation A offering statement (Form 1-A) on Jan 12, 2023 for up to $10M at $2.00 per security. The SEC qualified the offering on May 30, 2023. Underwriter or broker: S, t and a.
- Status
- Qualified
- Tier
- Tier 2
- Offering size
- $10M
- Offer price
- $2.00
- Security type
- Equity (common or preferred stock)
- Filed
- Jan 12, 2023
- Qualified
- May 30, 2023
- Industry
- Pharmaceutical Preparations
- State
- CA
- Underwriter / broker
- S, t, a, r, E, n, g, i, e, P, m, y, ,, L and C
More on this offering for subscribers
- Revenue, net income and total assets from the offering statement
- Employees
- Market cap at the offer price
- Auditor
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Offering statement (Form 1-A) Jan 12, 2023
- Final offering circular (253G2)
- All filings on EDGAR CIK 1905495
Other qualified Biotech & pharma Reg A offerings
- SciMar Ltd.Dec 21, 2023 · $55M
- Starpax Biopharma Inc.Sep 11, 2023 · $24M
- Sibannac, Inc.Mar 15, 2023 · $6M
- Algernon Neuroscience Inc.Mar 8, 2023 · $10M
- Shackelford Pharma Inc.Dec 12, 2022 · $12M
- MXY Holdings Inc.Oct 21, 2022 · $75M